Correlation between Aurora-A expression and the prognosis of cervical carcinoma patients

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 5, 2009, Pages 521-527

  Zhang, Wei ^a   Wang, Jian ^a   Liu, Shu Juan ^a   Hua, Wei ^a   Xin, Xiao Yan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Aurora A; Cervical carcinoma; Disease free survival; Overall survival; Prognositic factor; Reverse transcription polymerase chain reaction

Indexed keywords

AURORA A KINASE; MESSENGER RNA; AURORA KINASE; PROTEIN SERINE THREONINE KINASE;

ADULT; ARTICLE; BLOOD DISEASE; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CANCER TISSUE; CARCINOMA CELL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR DIFFERENTIATION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM; WESTERN BLOTTING; CANCER STAGING; CARCINOMA; DISEASE COURSE; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM; MORTALITY; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; SURVIVAL; TUMOR CELL LINE; UPREGULATION; UTERINE CERVIX TUMOR;

BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 65649110549     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340902835927     Document Type: Article

References (25)

1. Thomas GM. Improved treatment for cervical cancer -concurrent chemotherapy and radiotherapy. N Engl J Med. 1999;340:1198-200.
2. Burghardt E, Pickel H, Haas J, Lahousen M. Prognostic factors and operative treatment of stage IB to IIB cervical cancer. Am J Obstet Gynecol. 1987;156:988-96.
3. Van Bommell PFJ, van Lindert ACM, Kock HCLV, Leers WH, Neijt JP. A review of prognostic factors in early-stage carcinoma of the cervix (FIGO IB and IIA) and implications for treatment strategy. Eur J Obstet Gynecol Reprod Biol. 1987;26:69-84.
4. Kollareddy M, Dzubak P, Zheleva D, Hajduch M. Aurora kinases: structure, functions and their association with cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008;152:27-33.
5. Carmena M, Earnshaw WC. The cellular geography of Aurora kinases. Nat Rev Mol Cell Biol. 2003;4:842-54.
6. Vader G, Lens SM. The Aurora kinase family in cell division and cancer. Biochim Biophys Acta. 2008;1786:60-72.
7. Sen S, Zhou H, White RA. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene. 1997;14:2195-200.
8. Yang SB, Zhou XB, Zhu HX, Quan LP, Bai JF, He J, et al. Amplification and overexpression of Aurora-A in esophageal squamous cell carcinoma. Oncol Rep. 2007;17:1083-8.
9. Gritsko TM, Coppola D, Paciga JE, Yang L, Sun M, Shelley SA, et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res. 2003;9:1420-6.
10. Nishida N, Nagasaka T, Kashiwagi K, Boland CR, Goel A. High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers. Cancer Biol Ther. 2007;6:525-33.
11. Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res. 2003;9: 991-7.
12. Kamada K, Yamada Y, Hirao T, Fujimoto H, Takahama Y, Ueno M, et al. Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis. Oncol Rep. 2004;12:593-9.
13. Globocan 2000. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No 5 (Version 1-0). Lyon, France: IARC Press, 2001.
14. Scambia G, Benedetti Panici P, Foti E, Amoroso M, Salerno G, Ferrandina G, et al. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer. J Clin Oncol. 1994;12:2309-16.
15. Duk JM, Groenier KH, de Bruijn HW, Hollema H, ten Hoor KA, van der Zee AG, et al. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J Clin Oncol. 1996;14:111-8.
16. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nat Rev Mol Cell Biol. 2001;2:21-32.
17. Bischoff JR, Plowman GD. The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol. 1999;9:454-9.
18. Lentini L, Amato A, Schillaci T, Di Leonardo A. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype. BMC Cancer. 2007;7:212-24.
19. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998;20:189-93.
20. Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 2003;22:451-64.
21. McGrogan BT, Gilmartin B, Carney DN, McCann A. Taxanes, microtubules and chemoresistant breast cancer. Biochim Biophys Acta. 2008;1785:96-132.
22. Yang H, He L, Kruk P, Nicosia SV, Cheng JQ. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Int J Cancer. 2006;119:2304-12.
23. Guan Z, Wang XR, Zhu XF, Huang XF, Xu J, Wang LH, et al. Aurora-A, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells. Cancer Res. 2007;67:10436-44.
24. Tanaka E, Hashimoto Y, Ito T, Kondo K, Higashiyama M, Tsunoda S, et al. The suppression of aurora-A/STK15/BTAK expression enhances chemosensitivity to docetaxel in human esophageal squamous cell carcinoma. Clin Cancer Res. 2007; 13:1331-40.
25. Carvajal RD, Tse A, Schwartz GK. Aurora kinases: new targets for cancer therapy. Clin Cancer Res. 2006;12: 6869-75.